{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/305739245"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "These changes were brought about as the result of a stock purchase agreement changing majority ownership of the company. ???Dr. Sablin, who has a track record of excellence in drug discovery and development, is a founder of Selena Pharmaceuticals and a co-founder of Medivation, companies that advanced Dimebon, a Phase III technology that resulted in a deal with Pfizer with an over $200 million in" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "health-plan-news.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/139625161"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/305739245"] } } }
